Results

Merck & Co. Inc.

11/30/2021 | Press release | Distributed by Public on 11/30/2021 16:55

Merck and Ridgeback Statement on Positive FDA Advisory Committee Vote for Investigational Oral Antiviral Molnupiravir for Treatment of Mild to Moderate COVID-19 in High Risk Adults